ArTara Therapeutics, Inc. (TARA)

Last Price: 19.41 (2021-01-15)

Consolidated Net Income/Loss (Quarterly)

Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.

ArTara Therapeutics, Inc. (TARA) had Consolidated Net Income/Loss of $-7.97M for the most recently reported fiscal quarter, ending 2020-09-30.

Figures for fiscal quarter ending 2020-09-30
Income Statement Financials
--
$-7.97M
--
--
$8.06M
$-8.06M
$0.09M
$-7.97M
$-7.97M
$-7.97M
$-7.97M
Consolidated Net Income/Loss
$-7.97M
$-7.97M
$-8.06M
$-8.01M
6.32M
6.32M
$-1.26
$-1.26
Balance Sheet Financials
$167.12M
$0.76M
$31.79M
$198.91M
$3.89M
--
$0.39M
$4.28M
$194.63M
$165.26M
$194.63M
10.52M
Cash Flow Statement Financials
$-16.64M
$3.35M
$178.69M
$0.56M
$165.95M
$165.39M
$7.41M
--
--
Fundamental Metrics & Ratios
43.00
--
--
--
0.00
--
--
--
--
--
--
$-17.01M
--
--
--
--
--
--
--
-4.10%
-4.82%
-4.01%
-4.10%
$18.50
$-2.69
$-2.63